Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Viridian Therapeutics, Inc.\DE | Chief Legal Officer | Restricted Stock Units | 20.7K | $484K | $23.41 | Mar 3, 2025 | Direct |
Viridian Therapeutics, Inc.\DE | Chief Legal Officer | Stock Option (Right to Buy) | 124K | Mar 3, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics, Inc.\DE | Mar 3, 2025 | 2 | $0 | 4 | Mar 4, 2025 | Chief Legal Officer |
VRDN | Viridian Therapeutics, Inc.\DE | Feb 12, 2024 | 0 | $0 | 3 | Feb 14, 2024 | Chief Legal Officer |
VRDN | Viridian Therapeutics, Inc.\DE | Feb 12, 2024 | 1 | $0 | 4 | Feb 14, 2024 | Chief Legal Officer |